Healthcare Sector Stocks
The Healthcare sector has a total of 1066 stocks, with a combined market cap of $8.17 trillion, total revenue of $4.53 trillion and a weighted average PE ratio of 40.67.
Market Cap
8.17T
Revenue
4.53T
Profits
201B
PE Ratio
40.67
Profit Margin
4.44%
Dividend Yield
0.43%
1067 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 785.65B | -0.67% | 1,178,228 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 542.83B | -0.88% | 3,205,463 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 350.92B | -0.16% | 3,768,879 | 61.16B |
| 4 | UNH | UnitedHealth Group Incorporated | 318.58B | -1.17% | 3,250,807 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 292.25B | -0.83% | 980,160 | 58.74B |
| 6 | NVS | Novartis AG | 277.41B | -0.48% | 979,665 | 56.67B |
| 7 | MRK | Merck & Co., Inc. | 274.68B | -0.62% | 3,697,012 | 65.01B |
| 8 | AMGN | Amgen Inc. | 185.07B | -0.47% | 1,162,489 | 36.75B |
| 9 | NVO | Novo Nordisk A/S | 180.69B | 0.41% | 14,698,986 | 48.59B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 173.53B | -0.58% | 889,980 | 45.20B |
| 11 | ISRG | Intuitive Surgical, Inc. | 167.80B | -1.75% | 771,746 | 10.58B |
| 12 | ABT | Abbott Laboratories | 161.13B | 1.52% | 7,603,038 | 45.13B |
| 13 | GILD | Gilead Sciences, Inc. | 158.83B | -1.87% | 2,901,721 | 29.44B |
| 14 | PFE | Pfizer Inc. | 152.90B | -0.44% | 16,213,590 | 62.58B |
| 15 | DHR | Danaher Corporation | 127.70B | 1.79% | 2,537,009 | 24.78B |
| 16 | SYK | Stryker Corporation | 125.54B | 0.09% | 867,916 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 118.91B | -0.80% | 5,022,434 | 48.19B |
| 18 | SNY | Sanofi | 113.21B | -1.52% | 1,397,247 | 54.85B |
| 19 | GSK | GSK plc | 108.87B | -0.20% | 1,643,528 | 43.97B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 108.84B | -0.56% | 322,131 | 12.00B |
| 21 | MDT | Medtronic plc | 106.41B | -0.53% | 3,119,764 | 35.48B |
| 22 | MCK | McKesson Corporation | 100.95B | -0.48% | 307,391 | 397.96B |
| 23 | CVS | CVS Health Corporation | 100.02B | 0.13% | 2,984,235 | 399.83B |
| 24 | HCA | HCA Healthcare, Inc. | 98.56B | 1.94% | 770,520 | 76.39B |
| 25 | BSX | Boston Scientific Corporation | 90.06B | -2.37% | 7,154,847 | 20.61B |
| 26 | ELV | Elevance Health, Inc. | 76.77B | 2.54% | 991,799 | 200.42B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 75.86B | -0.79% | 175,029 | 14.34B |
| 28 | CI | The Cigna Group | 73.99B | 1.81% | 607,995 | 274.90B |
| 29 | COR | Cencora, Inc. | 60.38B | 0.71% | 501,943 | 325.78B |
| 30 | MDLN | Medline Inc. | 59.05B | 0.42% | 933,475 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 51.68B | -1.50% | 1,295,840 | 28.48B |
| 32 | ZTS | Zoetis Inc. | 49.83B | 1.39% | 1,557,756 | 9.47B |
| 33 | EW | Edwards Lifesciences Corporation | 48.76B | 0.50% | 3,193,457 | 6.30B |
| 34 | ARGX | argenx SE | 48.50B | 1.12% | 158,516 | 4.24B |
| 35 | CAH | Cardinal Health, Inc. | 47.77B | 1.58% | 863,001 | 244.67B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.76B | 1.80% | 229,602 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 42.96B | -0.84% | 798,769 | 21.92B |
| 38 | HLN | Haleon plc | 42.68B | -0.78% | 3,056,811 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.69B | 0.41% | 492,068 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.17B | 0.30% | 536,499 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 36.18B | 1.40% | 4,731,428 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 33.12B | -0.71% | 101,484 | 5.34B |
| 43 | A | Agilent Technologies, Inc. | 32.74B | 0.27% | 482,977 | 7.07B |
| 44 | RMD | ResMed Inc. | 32.21B | 1.01% | 462,871 | 5.40B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 31.93B | 1.67% | 2,380,472 | 20.63B |
| 46 | WAT | Waters Corporation | 29.97B | -1.48% | 313,166 | 3.17B |
| 47 | RPRX | Royalty Pharma plc | 29.41B | 0.47% | 1,496,347 | 2.38B |
| 48 | INSM | Insmed Incorporated | 29.40B | 0.75% | 494,982 | 606.42M |
| 49 | NTRA | Natera, Inc. | 29.21B | 1.14% | 609,192 | 2.31B |
| 50 | RVMD | Revolution Medicines, Inc. | 27.73B | -2.54% | 2,029,854 | - |
| 51 | IQV | IQVIA Holdings Inc. | 27.46B | 0.81% | 343,098 | 16.31B |
| 52 | BIIB | Biogen Inc. | 26.63B | -1.59% | 460,454 | 9.89B |
| 53 | HUM | Humana Inc. | 26.38B | 2.10% | 472,283 | 129.66B |
| 54 | VEEV | Veeva Systems Inc. | 26.36B | 0.17% | 617,238 | 3.20B |
| 55 | BNTX | BioNTech SE | 25.97B | -2.63% | 472,345 | 3.37B |
| 56 | PHG | Koninklijke Philips N.V. | 25.94B | 0.20% | 638,467 | 20.94B |
| 57 | MTD | Mettler-Toledo International Inc. | 25.75B | -0.83% | 39,568 | 4.03B |
| 58 | UTHR | United Therapeutics Corporation | 24.93B | 0.31% | 82,317 | 3.18B |
| 59 | DXCM | DexCom, Inc. | 23.72B | -0.16% | 1,346,683 | 4.66B |
| 60 | STE | STERIS plc | 21.76B | 0.02% | 199,995 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.74B | 0.07% | 205,214 | 11.28B |
| 62 | LH | Labcorp Holdings Inc. | 21.71B | 0.12% | 211,587 | 13.95B |
| 63 | WST | West Pharmaceutical Services, Inc. | 21.30B | -1.51% | 494,627 | 3.22B |
| 64 | CNC | Centene Corporation | 21.17B | 2.92% | 3,449,704 | 176.15B |
| 65 | ROIV | Roivant Sciences Ltd. | 19.87B | 1.30% | 2,557,521 | 13.31M |
| 66 | MRNA | Moderna, Inc. | 19.46B | -3.25% | 2,717,044 | 1.94B |
| 67 | ILMN | Illumina, Inc. | 19.42B | -0.05% | 446,292 | 4.34B |
| 68 | INCY | Incyte Corporation | 18.95B | 0.59% | 860,389 | 5.14B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.84B | 1.01% | 1,068,977 | 8.23B |
| 70 | SMMT | Summit Therapeutics Inc. | 17.43B | 1.72% | 2,322,359 | - |
| 71 | VTRS | Viatris Inc. | 17.16B | 0.99% | 2,329,503 | 14.30B |
| 72 | GMAB | Genmab A/S | 16.46B | -0.60% | 523,585 | 3.72B |
| 73 | THC | Tenet Healthcare Corporation | 16.08B | 1.53% | 803,891 | 21.31B |
| 74 | BBIO | BridgeBio Pharma, Inc. | 14.50B | 2.07% | 1,989,354 | 502.08M |
| 75 | RGC | Regencell Bioscience Holdings Limited | 14.44B | 6.22% | 101,608 | - |
| 76 | ASND | Ascendis Pharma A/S | 14.05B | -0.81% | 302,136 | 845.52M |
| 77 | SNN | Smith & Nephew plc | 13.35B | 1.24% | 816,732 | 6.16B |
| 78 | ALGN | Align Technology, Inc. | 13.30B | -2.04% | 603,731 | 4.03B |
| 79 | PODD | Insulet Corporation | 13.06B | -0.55% | 230,296 | 2.71B |
| 80 | PEN | Penumbra, Inc. | 12.91B | -0.46% | 103,183 | 1.40B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 12.89B | 0.41% | 459,328 | 2.86B |
| 82 | GMED | Globus Medical, Inc. | 12.75B | -0.93% | 316,899 | 2.94B |
| 83 | COO | The Cooper Companies, Inc. | 12.58B | 0.11% | 842,308 | 4.15B |
| 84 | JAZZ | Jazz Pharmaceuticals plc | 12.44B | 2.86% | 309,381 | 4.27B |
| 85 | FMS | Fresenius Medical Care AG | 12.27B | -0.48% | 260,242 | 23.05B |
| 86 | SOLV | Solventum Corporation | 12.02B | 1.20% | 329,613 | 8.33B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.99B | 1.97% | 105,192 | 958.40M |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 11.98B | -1.04% | 685,191 | 943.71M |
| 89 | MEDP | Medpace Holdings, Inc. | 11.86B | 1.14% | 194,156 | 2.68B |
| 90 | RDY | Dr. Reddy's Laboratories Limited | 11.80B | 2.08% | 721,945 | 3.85B |
| 91 | GH | Guardant Health, Inc. | 11.79B | 1.14% | 565,765 | 982.02M |
| 92 | EXEL | Exelixis, Inc. | 11.37B | -0.42% | 914,936 | 2.32B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.20B | -1.45% | 3,718,853 | 4.72B |
| 94 | ENSG | The Ensign Group, Inc. | 11.14B | 0.81% | 132,872 | 5.06B |
| 95 | UHS | Universal Health Services, Inc. | 10.89B | 2.30% | 474,704 | 17.36B |
| 96 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.36B | 0.11% | 644,115 | 1.09B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.34B | 1.07% | 617,857 | 3.22B |
| 98 | EHC | Encompass Health Corporation | 10.10B | -0.35% | 196,375 | 5.94B |
| 99 | DVA | DaVita Inc. | 9.98B | -0.37% | 170,694 | 13.64B |
| 100 | BTSG | BrightSpring Health Services, Inc. | 9.96B | 0.91% | 1,194,454 | 12.91B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 9.78B | 2.79% | 460,844 | 638.50M |
| 102 | RVTY | Revvity, Inc. | 9.74B | 0.39% | 334,553 | 2.86B |
| 103 | TEM | Tempus AI, Inc. | 9.56B | 2.38% | 1,692,228 | 1.27B |
| 104 | BAX | Baxter International Inc. | 9.46B | 0.85% | 2,673,307 | 11.24B |
| 105 | MOH | Molina Healthcare, Inc. | 9.34B | 1.86% | 636,632 | 43.10B |
| 106 | MASI | Masimo Corporation | 9.32B | -0.01% | 221,906 | 1.53B |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 9.25B | -3.72% | 195,177 | 7.46M |
| 108 | ABVX | ABIVAX Société Anonyme | 8.98B | -1.96% | 483,332 | 5.37M |
| 109 | HSIC | Henry Schein, Inc. | 8.90B | 0.04% | 428,157 | 13.18B |
| 110 | PCVX | Vaxcyte, Inc. | 8.59B | 0.29% | 467,987 | - |
| 111 | TECH | Bio-Techne Corporation | 8.57B | 1.06% | 601,501 | 1.22B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.44B | 0.74% | 292,071 | 4.02B |
| 113 | NUVL | Nuvalent, Inc. | 8.22B | 0.03% | 203,141 | - |
| 114 | ATR | AptarGroup, Inc. | 8.01B | 1.19% | 108,053 | 3.78B |
| 115 | KRYS | Krystal Biotech, Inc. | 7.97B | -0.65% | 136,257 | 389.13M |
| 116 | QGEN | Qiagen N.V. | 7.91B | -0.47% | 759,878 | 2.09B |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 7.82B | 0.62% | 61,832 | 2.58B |
| 118 | CYTK | Cytokinetics, Incorporated | 7.80B | -3.84% | 1,070,432 | 88.04M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.74B | 0.02% | 444,574 | 1.40B |
| 120 | ICLR | ICON Public Limited Company | 7.70B | -1.31% | 1,273,634 | 8.10B |
| 121 | IBRX | ImmunityBio, Inc. | 7.47B | -2.76% | 6,340,428 | 113.29M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 3.72% | 193,925 | 39.21M |
| 123 | GKOS | Glaukos Corporation | 7.12B | 0.12% | 314,562 | 507.44M |
| 124 | HQY | HealthEquity, Inc. | 7.09B | 1.74% | 319,562 | 1.31B |
| 125 | HIMS | Hims & Hers Health, Inc. | 6.80B | -2.36% | 14,108,228 | 2.35B |
| 126 | ACLX | Arcellx, Inc. | 6.75B | 0.08% | 1,608,204 | 22.29M |
| 127 | RGEN | Repligen Corporation | 6.66B | 0.44% | 241,352 | 738.26M |
| 128 | GRFS | Grifols, S.A. | 6.53B | 0.19% | 646,730 | 8.83B |
| 129 | BLTE | Belite Bio, Inc | 6.37B | 0.37% | 35,967 | - |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.36B | 0.58% | 338,914 | - |
| 131 | PTGX | Protagonist Therapeutics, Inc. | 6.36B | -0.39% | 452,594 | 46.02M |
| 132 | ERAS | Erasca, Inc. | 6.17B | -7.63% | 10,379,048 | - |
| 133 | SYRE | Spyre Therapeutics, Inc. | 6.12B | 1.78% | 331,193 | - |
| 134 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.12% | 1,994,808 | - |
| 135 | CNTA | Centessa Pharmaceuticals plc | 6.11B | 0.06% | 1,201,143 | 15.00M |
| 136 | TFX | Teleflex Incorporated | 6.02B | -0.46% | 189,317 | 1.99B |
| 137 | CELC | Celcuity Inc. | 5.94B | 1.55% | 508,842 | - |
| 138 | IMVT | Immunovant, Inc. | 5.89B | 1.26% | 336,817 | - |
| 139 | COGT | Cogent Biosciences, Inc. | 5.89B | -0.65% | 391,143 | - |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.86B | 0.07% | 140,096 | 189.76M |
| 141 | PTCT | PTC Therapeutics, Inc. | 5.75B | 1.58% | 230,121 | 1.73B |
| 142 | BLCO | Bausch + Lomb Corporation | 5.74B | 1.83% | 136,447 | 5.10B |
| 143 | CAI | Caris Life Sciences, Inc. | 5.72B | 0.15% | 543,976 | 812.03M |
| 144 | CGON | CG Oncology, Inc. | 5.66B | -2.34% | 305,682 | 4.04M |
| 145 | CHE | Chemed Corporation | 5.66B | 0.16% | 147,271 | 2.54B |
| 146 | ALKS | Alkermes plc | 5.62B | 1.41% | 468,936 | 1.48B |
| 147 | PACS | PACS Group, Inc. | 5.58B | 0.17% | 314,294 | 5.29B |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 5.58B | 1.00% | 215,188 | 521.31M |
| 149 | BRKR | Bruker Corporation | 5.52B | -0.71% | 480,768 | 3.44B |
| 150 | LNTH | Lantheus Holdings, Inc. | 5.48B | 0.11% | 178,994 | 1.54B |
| 151 | AVTR | Avantor, Inc. | 5.42B | 1.39% | 3,984,783 | 6.55B |
| 152 | TGTX | TG Therapeutics, Inc. | 5.33B | -1.53% | 574,938 | 616.29M |
| 153 | SRRK | Scholar Rock Holding Corporation | 5.29B | -0.86% | 587,826 | - |
| 154 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 1,802,354 | 1.00B |
| 155 | XENE | Xenon Pharmaceuticals Inc. | 5.21B | -1.18% | 241,712 | 7.50M |
| 156 | OSCR | Oscar Health, Inc. | 5.11B | 2.26% | 3,148,240 | 11.70B |
| 157 | CRSP | CRISPR Therapeutics AG | 4.97B | 5.87% | 1,891,474 | 3.51M |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.94B | -0.13% | 291,891 | 761.41M |
| 159 | WAY | Waystar Holding Corp. | 4.89B | 0.28% | 499,475 | 1.10B |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 4.72B | -0.90% | 214,403 | 2.04M |
| 161 | RDNT | RadNet, Inc. | 4.65B | 3.12% | 242,335 | 2.04B |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 4.64B | 0.71% | 130,900 | 268.09M |
| 163 | DOCS | Doximity, Inc. | 4.57B | 3.08% | 1,171,008 | 637.78M |
| 164 | FOLD | Amicus Therapeutics, Inc. | 4.55B | - | - | 634.21M |
| 165 | SHC | Sotera Health Company | 4.49B | 1.06% | 789,229 | 1.16B |
| 166 | STVN | Stevanato Group S.p.A. | 4.40B | -0.34% | 110,298 | 1.39B |
| 167 | OPCH | Option Care Health, Inc. | 4.39B | -1.44% | 630,946 | 5.65B |
| 168 | NVST | Envista Holdings Corporation | 4.37B | - | 618,896 | 2.72B |
| 169 | LEGN | Legend Biotech Corporation | 4.36B | -1.38% | 668,808 | 1.03B |
| 170 | ALHC | Alignment Healthcare, Inc. | 4.31B | -0.09% | 1,847,183 | 3.95B |
| 171 | IRTC | iRhythm Holdings, Inc. | 4.14B | 3.60% | 216,946 | 747.14M |
| 172 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.05B | 0.91% | 345,577 | 7.70M |
| 173 | ORKA | Oruka Therapeutics, Inc. | 4.02B | 15.94% | 5,108,257 | - |
| 174 | AMRX | Amneal Pharmaceuticals, Inc. | 4.01B | 0.48% | 594,382 | 3.02B |
| 175 | MMSI | Merit Medical Systems, Inc. | 4.01B | -1.97% | 279,345 | 1.52B |
| 176 | BLLN | BillionToOne, Inc. | 3.86B | -1.04% | 101,587 | 305.11M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.84B | 2.60% | 356,514 | 1.07B |
| 178 | VKTX | Viking Therapeutics, Inc. | 3.82B | 0.70% | 836,348 | - |
| 179 | TNGX | Tango Therapeutics, Inc. | 3.81B | 2.60% | 1,312,301 | 62.38M |
| 180 | TVTX | Travere Therapeutics, Inc. | 3.79B | 1.33% | 468,434 | 490.73M |
| 181 | TMDX | TransMedics Group, Inc. | 3.74B | -2.36% | 355,573 | 605.49M |
| 182 | TWST | Twist Bioscience Corporation | 3.70B | -0.85% | 330,788 | 391.56M |
| 183 | MMED | MiniMed Group, Inc. | 3.65B | -1.67% | 160,104 | 2.99B |
| 184 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.57B | 6.87% | 6,933,656 | 588.99M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.56B | -1.52% | 54,313 | 803.79M |
| 186 | HNGE | Hinge Health, Inc. | 3.49B | 1.96% | 232,478 | 587.86M |
| 187 | NAMS | NewAmsterdam Pharma Company N.V. | 3.47B | 1.51% | 612,089 | 22.50M |
| 188 | OGN | Organon & Co. | 3.46B | 17.10% | 107,105,518 | 6.22B |
| 189 | LIVN | LivaNova PLC | 3.46B | -1.54% | 309,909 | 1.39B |
| 190 | MANE | Veradermics, Incorporated | 3.38B | 33.46% | 2,518,432 | - |
| 191 | EWTX | Edgewise Therapeutics, Inc. | 3.32B | -1.87% | 420,869 | - |
| 192 | BKD | Brookdale Senior Living Inc. | 3.32B | 0.54% | 555,794 | 3.05B |
| 193 | LQDA | Liquidia Corporation | 3.31B | 0.56% | 440,123 | 158.32M |
| 194 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.31B | 0.53% | 301,678 | 677.56M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.26B | 1.01% | 328,073 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.19B | -0.29% | 223,393 | 247.00M |
| 197 | DNLI | Denali Therapeutics Inc. | 3.17B | 0.65% | 327,815 | - |
| 198 | ALMS | Alumis Inc. | 3.16B | -0.32% | 520,133 | 24.05M |
| 199 | ICUI | ICU Medical, Inc. | 3.06B | -1.87% | 129,682 | 2.23B |
| 200 | PRVA | Privia Health Group, Inc. | 3.05B | 1.85% | 258,612 | 2.12B |
| 201 | NKTR | Nektar Therapeutics | 2.98B | -3.59% | 676,348 | 55.23M |
| 202 | DYN | Dyne Therapeutics, Inc. | 2.98B | -1.20% | 949,805 | - |
| 203 | BEAM | Beam Therapeutics Inc. | 2.96B | 9.15% | 2,141,287 | 139.74M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 2.93B | 0.56% | 375,530 | 376.07M |
| 205 | CON | Concentra Group Holdings Parent, Inc. | 2.91B | -0.88% | 128,581 | 2.16B |
| 206 | TXG | 10x Genomics, Inc. | 2.89B | 2.36% | 1,279,285 | 642.82M |
| 207 | SUPN | Supernus Pharmaceuticals, Inc. | 2.86B | -0.22% | 298,613 | 718.95M |
| 208 | ITGR | Integer Holdings Corporation | 2.86B | -2.55% | 164,286 | 1.85B |
| 209 | LFST | LifeStance Health Group, Inc. | 2.85B | 3.76% | 1,575,694 | 1.42B |
| 210 | HAE | Haemonetics Corporation | 2.84B | 1.92% | 254,094 | 1.32B |
| 211 | WRBY | Warby Parker Inc. | 2.82B | 0.83% | 596,916 | 871.91M |
| 212 | RLAY | Relay Therapeutics, Inc. | 2.81B | -1.92% | 1,084,032 | 15.36M |
| 213 | PBH | Prestige Consumer Healthcare Inc. | 2.76B | -1.10% | 332,595 | 1.10B |
| 214 | NHC | National HealthCare Corporation | 2.75B | 2.04% | 50,469 | 1.52B |
| 215 | KLRA | Kailera Therapeutics, Inc. | 2.74B | -1.25% | 619,178 | - |
| 216 | HTFL | HeartFlow, Inc. | 2.74B | 4.83% | 408,882 | 176.03M |
| 217 | IMNM | Immunome, Inc. | 2.73B | 2.33% | 489,205 | 6.94M |
| 218 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.01% | 512,032 | 190.41M |
| 219 | KOD | Kodiak Sciences Inc. | 2.72B | -1.83% | 216,436 | - |
| 220 | VCYT | Veracyte, Inc. | 2.72B | -0.39% | 261,318 | 517.15M |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.67B | 0.95% | 298,428 | - |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.67B | 2.18% | 297,472 | 1.55M |
| 223 | VERA | Vera Therapeutics, Inc. | 2.67B | -1.35% | 353,318 | - |
| 224 | LMAT | LeMaitre Vascular, Inc. | 2.63B | 1.37% | 101,642 | 249.60M |
| 225 | IRON | Disc Medicine, Inc. | 2.61B | -0.50% | 81,647 | - |
| 226 | IDYA | IDEAYA Biosciences, Inc. | 2.60B | -3.55% | 343,336 | 218.71M |
| 227 | ADMA | ADMA Biologics, Inc. | 2.59B | -1.07% | 2,066,184 | 510.17M |
| 228 | TARS | Tarsus Pharmaceuticals, Inc. | 2.58B | -1.43% | 294,256 | 451.36M |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.54B | 0.77% | 744,711 | 3.31B |
| 230 | ZLAB | Zai Lab Limited | 2.47B | -3.56% | 114,937 | 460.16M |
| 231 | GRDN | Guardian Pharmacy Services, Inc. | 2.42B | 1.65% | 193,827 | 1.45B |
| 232 | XRAY | DENTSPLY SIRONA Inc. | 2.38B | -0.04% | 2,266,461 | 3.68B |
| 233 | RARE | Ultragenyx Pharmaceutical Inc. | 2.36B | -0.17% | 508,503 | 673.00M |
| 234 | HCM | HUTCHMED (China) Limited | 2.33B | -3.36% | 11,630 | 548.51M |
| 235 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.28B | 1.57% | 1,287,105 | 874.84M |
| 236 | PAHC | Phibro Animal Health Corporation | 2.26B | 1.14% | 45,952 | 1.46B |
| 237 | MLYS | Mineralys Therapeutics, Inc. | 2.25B | -0.95% | 343,209 | - |
| 238 | GRAL | GRAIL, Inc. | 2.24B | 0.35% | 226,104 | 147.17M |
| 239 | TYRA | Tyra Biosciences, Inc. | 2.21B | -1.36% | 404,360 | - |
| 240 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 0.28% | 468,021 | 276.98M |
| 241 | SRPT | Sarepta Therapeutics, Inc. | 2.17B | 1.72% | 1,525,764 | 2.20B |
| 242 | AAPG | Ascentage Pharma Group International | 2.17B | -3.55% | 982 | 82.08M |
| 243 | DFTX | Definium Therapeutics, Inc. | 2.13B | -4.80% | 988,563 | - |
| 244 | BHC | Bausch Health Companies Inc. | 2.13B | 1.42% | 823,997 | 10.27B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.13B | 2.50% | 654,154 | 283.06M |
| 246 | ZYME | Zymeworks Inc. | 2.10B | 1.57% | 399,461 | 105.97M |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.08B | 0.63% | 1,350,588 | 51.95M |
| 248 | NEOG | Neogen Corporation | 2.07B | -0.42% | 534,386 | 870.56M |
| 249 | AXGN | Axogen, Inc. | 2.05B | 0.66% | 621,327 | 225.21M |
| 250 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 166,045 | 5.45B |
| 251 | TRVI | Trevi Therapeutics, Inc. | 2.03B | 0.56% | 464,539 | - |
| 252 | STOK | Stoke Therapeutics, Inc. | 2.00B | -0.56% | 93,391 | 184.42M |
| 253 | MESO | Mesoblast Limited | 1.99B | -1.10% | 53,196 | 65.38M |
| 254 | CAPR | Capricor Therapeutics, Inc. | 1.99B | -2.44% | 510,405 | 11.13M |
| 255 | WGS | GeneDx Holdings Corp. | 1.94B | -3.15% | 157,223 | 427.54M |
| 256 | ESTA | Establishment Labs Holdings Inc. | 1.94B | -0.23% | 111,814 | 211.08M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.89B | 0.47% | 353,640 | -665.00K |
| 258 | MD | Pediatrix Medical Group, Inc. | 1.89B | 1.13% | 219,753 | 1.91B |
| 259 | GLPG | Galapagos NV | 1.89B | -0.07% | 55,102 | 1.31B |
| 260 | SGRY | Surgery Partners, Inc. | 1.89B | 2.58% | 352,014 | 3.31B |
| 261 | ANAB | AnaptysBio, Inc. | 1.88B | 11.23% | 704,329 | 234.60M |
| 262 | PHVS | Pharvaris N.V. | 1.88B | 0.28% | 97,998 | - |
| 263 | INBX | Inhibrx Biosciences, Inc. | 1.87B | -0.94% | 350,328 | 1.30M |
| 264 | AHG | Akso Health Group | 1.85B | 6.14% | 218,339 | 14.84M |
| 265 | TSHA | Taysha Gene Therapies, Inc. | 1.85B | 0.63% | 987,800 | 9.77M |
| 266 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | -2.24% | 502,571 | 172.35M |
| 267 | RXRX | Recursion Pharmaceuticals, Inc. | 1.84B | -1.00% | 6,483,815 | 74.68M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.82B | 2.96% | 130,290 | - |
| 269 | VCEL | Vericel Corporation | 1.82B | 0.28% | 159,863 | 276.26M |
| 270 | HRMY | Harmony Biosciences Holdings, Inc. | 1.81B | 1.46% | 229,404 | 868.45M |
| 271 | AORT | Artivion, Inc. | 1.81B | -1.32% | 72,928 | 441.33M |
| 272 | ANIP | ANI Pharmaceuticals, Inc. | 1.80B | 0.61% | 75,645 | 883.37M |
| 273 | AHCO | AdaptHealth Corp. | 1.76B | 1.45% | 397,577 | 3.24B |
| 274 | ADUS | Addus HomeCare Corporation | 1.76B | 1.24% | 67,433 | 1.42B |
| 275 | OMCL | Omnicell, Inc. | 1.74B | 2.58% | 238,963 | 1.18B |
| 276 | INVA | Innoviva, Inc. | 1.74B | -0.30% | 129,772 | 411.33M |
| 277 | SION | Sionna Therapeutics, Inc. | 1.74B | 1.36% | 448,750 | - |
| 278 | ALMR | Alamar Biosciences, Inc. | 1.73B | 1.85% | 248,248 | 74.21M |
| 279 | NRIX | Nurix Therapeutics, Inc. | 1.72B | -0.42% | 219,524 | 71.78M |
| 280 | ASTH | Astrana Health, Inc. | 1.71B | 2.25% | 155,949 | 3.18B |
| 281 | SNDA | Sonida Senior Living, Inc. | 1.70B | 1.17% | 218,355 | 336.39M |
| 282 | RAPP | Rapport Therapeutics, Inc. | 1.70B | -2.63% | 128,742 | - |
| 283 | VIR | Vir Biotechnology, Inc. | 1.70B | 1.64% | 887,027 | 68.56M |
| 284 | NTLA | Intellia Therapeutics, Inc. | 1.68B | 4.04% | 17,127,693 | 67.67M |
| 285 | GENB | Generate Biomedicines, Inc. | 1.66B | 1.60% | 118,919 | 31.89M |
| 286 | NUVB | Nuvation Bio Inc. | 1.64B | -3.78% | 4,300,530 | 62.90M |
| 287 | ATAI | AtaiBeckley Inc. | 1.62B | -4.10% | 3,667,593 | 4.09M |
| 288 | OCS | Oculis Holding AG | 1.61B | 2.99% | 450,734 | 1.51M |
| 289 | NBTX | Nanobiotix S.A. | 1.60B | -0.19% | 38,154 | 38.27M |
| 290 | PRGO | Perrigo Company plc | 1.58B | -2.62% | 795,884 | 4.25B |
| 291 | INSP | Inspire Medical Systems, Inc. | 1.57B | -3.05% | 218,025 | 911.98M |
| 292 | ATEC | Alphatec Holdings, Inc. | 1.57B | -4.86% | 616,599 | 764.16M |
| 293 | MBX | MBX Biosciences, Inc. | 1.55B | 2.38% | 235,178 | - |
| 294 | GLUE | Monte Rosa Therapeutics, Inc. | 1.55B | -2.37% | 237,412 | 123.67M |
| 295 | PLSE | Pulse Biosciences, Inc. | 1.53B | -1.95% | 94,057 | 350.00K |
| 296 | IMTX | Immatics N.V. | 1.53B | 0.66% | 204,867 | 56.67M |
| 297 | UFPT | UFP Technologies, Inc. | 1.53B | -1.12% | 300,474 | 602.80M |
| 298 | HROW | Harrow, Inc. | 1.52B | 3.10% | 388,311 | 272.30M |
| 299 | DMRA | Damora Therapeutics, Inc. | 1.51B | 1.17% | 76,722 | - |
| 300 | HCSG | Healthcare Services Group, Inc. | 1.51B | -2.19% | 274,195 | 1.85B |
| 301 | ATRC | AtriCure, Inc. | 1.48B | -0.34% | 256,468 | 534.53M |
| 302 | ARDX | Ardelyx, Inc. | 1.48B | 1.09% | 1,418,336 | 407.32M |
| 303 | AVAH | Aveanna Healthcare Holdings Inc. | 1.47B | 3.21% | 326,916 | 2.43B |
| 304 | IMCR | Immunocore Holdings plc | 1.47B | -1.60% | 138,079 | 400.02M |
| 305 | BCAX | Bicara Therapeutics Inc. | 1.47B | -1.19% | 106,857 | - |
| 306 | IOVA | Iovance Biotherapeutics, Inc. | 1.46B | 2.91% | 5,964,823 | 263.50M |
| 307 | BHVN | Biohaven Ltd. | 1.45B | -2.13% | 489,059 | - |
| 308 | AGIO | Agios Pharmaceuticals, Inc. | 1.45B | -2.13% | 361,140 | 54.03M |
| 309 | MAZE | Maze Therapeutics, Inc. | 1.44B | 1.24% | 221,482 | 2.50M |
| 310 | PGNY | Progyny, Inc. | 1.44B | 1.32% | 631,617 | 1.29B |
| 311 | NVCR | NovoCure Limited | 1.44B | -0.56% | 282,236 | 655.35M |
| 312 | ENOV | Enovis Corporation | 1.42B | 2.57% | 306,354 | 2.25B |
| 313 | PGEN | Precigen, Inc. | 1.42B | -2.78% | 989,074 | 9.68M |
| 314 | ARDT | Ardent Health, Inc. | 1.42B | 2.48% | 127,158 | 6.32B |
| 315 | BFLY | Butterfly Network, Inc. | 1.40B | 3.28% | 2,423,894 | 97.61M |
| 316 | VRDN | Viridian Therapeutics, Inc. | 1.40B | -1.38% | 1,281,112 | 70.85M |
| 317 | TNDM | Tandem Diabetes Care, Inc. | 1.37B | -2.01% | 445,898 | 1.01B |
| 318 | OLMA | Olema Pharmaceuticals, Inc. | 1.36B | 0.64% | 257,066 | - |
| 319 | PRCT | PROCEPT BioRobotics Corporation | 1.35B | -1.72% | 473,706 | 308.05M |
| 320 | WVE | Wave Life Sciences Ltd. | 1.35B | -2.37% | 1,559,697 | 42.73M |
| 321 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | -0.44% | 478,347 | - |
| 322 | JBIO | Jade Biosciences, Inc. | 1.34B | 8.85% | 331,166 | - |
| 323 | SVRA | Savara Inc. | 1.34B | 3.13% | 680,841 | - |
| 324 | AVBP | ArriVent BioPharma, Inc. | 1.34B | -0.46% | 321,989 | - |
| 325 | NVAX | Novavax, Inc. | 1.31B | -2.31% | 1,270,806 | 1.12B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.30B | -0.49% | 55,339 | 83.72M |
| 327 | STAA | STAAR Surgical Company | 1.30B | 2.30% | 253,670 | 239.44M |
| 328 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -1.08% | 273,149 | - |
| 329 | CLOV | Clover Health Investments, Corp. | 1.28B | 0.21% | 1,809,961 | 1.92B |
| 330 | GHRS | GH Research PLC | 1.27B | 0.99% | 111,651 | - |
| 331 | ABCL | AbCellera Biologics Inc. | 1.26B | 0.36% | 5,688,454 | 75.13M |
| 332 | DBVT | DBV Technologies S.A. | 1.22B | 3.38% | 111,592 | 5.64M |
| 333 | MLTX | MoonLake Immunotherapeutics | 1.21B | -1.48% | 213,664 | - |
| 334 | CMPS | COMPASS Pathways plc | 1.20B | -6.89% | 3,568,979 | - |
| 335 | PHAR | Pharming Group N.V. | 1.17B | 1.20% | 8,023 | 376.13M |
| 336 | AZTA | Azenta, Inc. | 1.17B | -2.20% | 233,386 | 595.03M |
| 337 | NNNN | Anbio Biotechnology | 1.17B | -2.82% | 20,665 | 8.65M |
| 338 | URGN | UroGen Pharma Ltd. | 1.16B | -0.87% | 151,649 | 109.79M |
| 339 | CNMD | CONMED Corporation | 1.16B | 0.26% | 237,711 | 1.37B |
| 340 | AKTS | Aktis Oncology, Inc. | 1.15B | -1.98% | 68,719 | 6.50M |
| 341 | AVNS | Avanos Medical, Inc. | 1.15B | -0.12% | 1,235,566 | 701.20M |
| 342 | IRMD | IRADIMED CORPORATION | 1.15B | 1.09% | 45,509 | 83.81M |
| 343 | EYPT | EyePoint, Inc. | 1.14B | -1.02% | 388,299 | 31.37M |
| 344 | QURE | uniQure N.V. | 1.14B | - | 680,634 | 16.10M |
| 345 | SEPN | Septerna, Inc. | 1.13B | 2.31% | 159,163 | 45.95M |
| 346 | USPH | U.S. Physical Therapy, Inc. | 1.11B | 0.25% | 58,591 | 773.34M |
| 347 | EVO | Evotec SE | 1.11B | -0.63% | 16,638 | 925.65M |
| 348 | NEO | NeoGenomics, Inc. | 1.11B | 3.02% | 1,101,604 | 727.33M |
| 349 | CDNA | CareDx, Inc. | 1.10B | 1.53% | 205,704 | 379.81M |
| 350 | ZBIO | Zenas BioPharma, Inc. | 1.10B | 1.87% | 149,457 | 10.00M |
| 351 | INNV | InnovAge Holding Corp. | 1.09B | 1.38% | 117,599 | 915.37M |
| 352 | PNTG | The Pennant Group, Inc. | 1.07B | 2.43% | 60,703 | 947.71M |
| 353 | COLL | Collegium Pharmaceutical, Inc. | 1.07B | 1.29% | 126,255 | 780.57M |
| 354 | TDOC | Teladoc Health, Inc. | 1.06B | 2.43% | 1,411,723 | 2.53B |
| 355 | IVA | Inventiva S.A. | 1.06B | -1.65% | 95,449 | 7.94M |
| 356 | OMER | Omeros Corporation | 1.05B | 7.61% | 1,159,486 | - |
| 357 | ALVO | Alvotech | 1.05B | -1.04% | 209,407 | 588.90M |
| 358 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 0.33% | 445,725 | 291.85M |
| 359 | BLFS | BioLife Solutions, Inc. | 1.03B | -0.33% | 87,610 | 96.21M |
| 360 | PCRX | Pacira BioSciences, Inc. | 1.02B | 2.65% | 174,364 | 726.41M |
| 361 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | -1.37% | 525,094 | - |
| 362 | CRON | Cronos Group Inc. | 1.01B | -0.19% | 647,344 | 146.59M |
| 363 | GERN | Geron Corporation | 996.60M | 3.67% | 7,258,028 | 183.88M |
| 364 | KALV | KalVista Pharmaceuticals, Inc. | 996.28M | -0.92% | 495,212 | 73.62M |
| 365 | ANNX | Annexon, Inc. | 985.61M | 3.15% | 980,284 | - |
| 366 | AMPH | Amphastar Pharmaceuticals, Inc. | 971.53M | 1.89% | 161,724 | 719.89M |
| 367 | CERT | Certara, Inc. | 970.55M | 0.16% | 695,458 | 418.84M |
| 368 | FTRE | Fortrea Holdings Inc. | 954.64M | 4.18% | 861,945 | 2.72B |
| 369 | XNCR | Xencor, Inc. | 954.14M | 0.23% | 522,257 | 125.58M |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 946.68M | 2.60% | 261,846 | 1.02B |
| 371 | MRVI | Maravai LifeSciences Holdings, Inc. | 940.87M | 3.10% | 731,833 | 185.74M |
| 372 | CTMX | CytomX Therapeutics, Inc. | 936.08M | -2.27% | 1,216,725 | 76.20M |
| 373 | LBRX | LB Pharmaceuticals Inc | 925.65M | 5.04% | 117,588 | - |
| 374 | JANX | Janux Therapeutics, Inc. | 917.95M | 0.53% | 253,408 | 10.00M |
| 375 | INMD | InMode Ltd. | 911.10M | -0.14% | 198,879 | 370.50M |
| 376 | OPK | OPKO Health, Inc. | 910.88M | -2.44% | 832,115 | 606.88M |
| 377 | PHAT | Phathom Pharmaceuticals, Inc. | 907.09M | -2.39% | 662,415 | 175.11M |
| 378 | EVMN | Evommune, Inc. | 901.00M | -1.44% | 83,618 | 13.00M |
| 379 | SANA | Sana Biotechnology, Inc. | 891.72M | -1.22% | 1,655,970 | - |
| 380 | SDGR | Schrödinger, Inc. | 890.33M | 2.29% | 733,523 | 255.87M |
| 381 | SLS | SELLAS Life Sciences Group, Inc. | 887.14M | 10.76% | 4,869,675 | - |
| 382 | SSII | SS Innovations International, Inc. | 879.74M | 0.92% | 18,543 | 42.48M |
| 383 | DRUG | Bright Minds Biosciences Inc. | 872.11M | 0.94% | 115,678 | - |
| 384 | TALK | Talkspace, Inc. | 867.12M | 0.19% | 448,297 | 228.87M |
| 385 | ANRO | Alto Neuroscience, Inc. | 867.03M | 0.88% | 86,316 | - |
| 386 | OMDA | Omada Health, Inc. | 866.50M | 2.62% | 239,760 | 260.21M |
| 387 | TBPH | Theravance Biopharma, Inc. | 861.48M | 1.64% | 124,172 | 107.46M |
| 388 | CBIO | Crescent Biopharma, Inc. | 847.62M | 2.90% | 74,128 | 10.84M |
| 389 | ABUS | Arbutus Biopharma Corporation | 843.89M | 2.02% | 778,484 | 14.08M |
| 390 | IART | Integra LifeSciences Holdings Corporation | 840.94M | 2.08% | 247,703 | 1.64B |
| 391 | BVS | Bioventus Inc. | 840.69M | 0.20% | 153,122 | 568.09M |
| 392 | MGTX | MeiraGTx Holdings plc | 840.42M | -1.63% | 236,942 | 81.39M |
| 393 | QDEL | QuidelOrtho Corporation | 834.00M | 5.69% | 1,060,605 | 2.73B |
| 394 | KURA | Kura Oncology, Inc. | 822.83M | 0.11% | 348,680 | 67.48M |
| 395 | AMN | AMN Healthcare Services, Inc. | 819.90M | 4.23% | 211,910 | 2.73B |
| 396 | MNKD | MannKind Corporation | 818.31M | -1.85% | 1,305,693 | 348.97M |
| 397 | SPRY | ARS Pharmaceuticals, Inc. | 809.27M | -1.69% | 1,189,203 | 84.28M |
| 398 | CGEM | Cullinan Therapeutics, Inc. | 809.23M | 1.13% | 347,787 | - |
| 399 | BIOA | BioAge Labs, Inc. | 807.82M | 6.72% | 191,310 | 9.00M |
| 400 | CBLL | CeriBell, Inc. | 802.52M | 0.05% | 104,870 | 89.06M |
| 401 | GDRX | GoodRx Holdings, Inc. | 791.35M | - | 581,937 | 796.85M |
| 402 | DSGN | Design Therapeutics, Inc. | 788.79M | 2.08% | 126,638 | - |
| 403 | SGP | SpyGlass Pharma, Inc. | 785.36M | -0.11% | 98,313 | - |
| 404 | ALLO | Allogene Therapeutics, Inc. | 777.39M | -2.16% | 3,912,645 | 22.00K |
| 405 | TLRY | Tilray Brands, Inc. | 776.40M | -1.04% | 4,660,942 | 858.28M |
| 406 | TENX | Tenax Therapeutics, Inc. | 772.61M | 7.41% | 1,477,951 | - |
| 407 | CSTL | Castle Biosciences, Inc. | 767.40M | 3.56% | 129,208 | 344.23M |
| 408 | NUTX | Nutex Health Inc. | 759.48M | 0.69% | 62,582 | 875.26M |
| 409 | VOR | Vor Biopharma Inc. | 755.89M | 1.01% | 395,427 | - |
| 410 | SLDB | Solid Biosciences Inc. | 748.78M | -3.91% | 405,328 | - |
| 411 | RLMD | Relmada Therapeutics, Inc. | 731.07M | -3.33% | 876,602 | - |
| 412 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 723.50M | 2.96% | 374,784 | - |
| 413 | LXRX | Lexicon Pharmaceuticals, Inc. | 718.14M | 0.89% | 1,468,974 | 49.80M |
| 414 | ABSI | Absci Corporation | 716.14M | 18.78% | 7,647,806 | 2.80M |
| 415 | EHAB | Enhabit, Inc. | 696.68M | -0.04% | 129,240 | 1.06B |
| 416 | GYRE | Gyre Therapeutics, Inc. | 695.36M | 2.35% | 15,516 | 116.59M |
| 417 | DRTS | Alpha Tau Medical Ltd. | 693.52M | -2.60% | 297,185 | - |
| 418 | PRME | Prime Medicine, Inc. | 664.93M | 1.49% | 826,765 | 4.63M |
| 419 | FBRX | Forte Biosciences, Inc. | 663.60M | -1.24% | 49,639 | - |
| 420 | BWAY | BrainsWay Ltd. | 663.54M | -0.12% | 117,103 | 52.23M |
| 421 | ARVN | Arvinas, Inc. | 663.28M | -0.67% | 160,587 | 262.60M |
| 422 | IRWD | Ironwood Pharmaceuticals, Inc. | 658.76M | 2.80% | 606,134 | 296.15M |
| 423 | ETON | Eton Pharmaceuticals, Inc. | 642.00M | 2.22% | 127,271 | 79.95M |
| 424 | PSNL | Personalis, Inc. | 634.35M | -0.66% | 592,568 | 69.65M |
| 425 | HSTM | HealthStream, Inc. | 631.82M | 1.17% | 56,210 | 304.06M |
| 426 | TRAX | First Tracks Biotherapeutics, Inc. | 626.00M | -0.80% | 209,825 | - |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 612.27M | 2.44% | 372,623 | 7.83M |
| 428 | CRMD | CorMedix Inc. | 595.27M | 2.29% | 863,175 | 311.71M |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 587.01M | -1.49% | 329,745 | 106.47M |
| 430 | SIBN | SI-BONE, Inc. | 585.79M | -2.07% | 185,718 | 200.93M |
| 431 | PRTA | Prothena Corporation plc | 585.70M | 1.21% | 124,670 | 9.68M |
| 432 | NPCE | NeuroPace, Inc. | 585.31M | 2.62% | 80,078 | 99.99M |
| 433 | STTK | Shattuck Labs, Inc. | 585.00M | - | 183,363 | 1.00M |
| 434 | PHR | Phreesia, Inc. | 582.11M | 0.42% | 623,681 | 480.59M |
| 435 | AGMB | AgomAb Therapeutics NV | 576.07M | 6.97% | 156,894 | - |
| 436 | OCGN | Ocugen, Inc. | 570.40M | 1.51% | 2,869,391 | 4.41M |
| 437 | CTKB | Cytek Biosciences, Inc. | 568.19M | 0.45% | 301,359 | 201.49M |
| 438 | PROK | ProKidney Corp. | 567.69M | -3.09% | 312,587 | 893.00K |
| 439 | RIGL | Rigel Pharmaceuticals, Inc. | 564.56M | 0.86% | 85,048 | 294.28M |
| 440 | TCMD | Tactile Systems Technology, Inc. | 563.53M | -1.20% | 92,829 | 329.52M |
| 441 | ANL | Adlai Nortye Ltd. | 554.40M | -6.35% | 337,704 | 5.00M |
| 442 | KYTX | Kyverna Therapeutics, Inc. | 550.22M | 0.33% | 686,515 | - |
| 443 | EMBC | Embecta Corp. | 548.97M | 0.54% | 320,851 | 1.08B |
| 444 | STRO | Sutro Biopharma, Inc. | 548.21M | -0.72% | 52,584 | 102.48M |
| 445 | ALT | Altimmune, Inc. | 540.85M | -2.28% | 3,326,621 | 41.00K |
| 446 | TECX | Tectonic Therapeutic, Inc. | 537.01M | 0.21% | 74,544 | - |
| 447 | VREX | Varex Imaging Corporation | 529.44M | 0.80% | 93,616 | 854.40M |
| 448 | AVR | Anteris Technologies Global Corp. | 527.86M | -0.54% | 220,140 | 1.91M |
| 449 | LYEL | Lyell Immunopharma, Inc. | 523.02M | 0.04% | 27,605 | 36.00K |
| 450 | IMMX | Immix Biopharma, Inc. | 514.75M | -1.42% | 288,297 | - |
| 451 | ZURA | Zura Bio Limited | 509.51M | -0.19% | 166,235 | - |
| 452 | FULC | Fulcrum Therapeutics, Inc. | 509.49M | -2.42% | 536,945 | 80.00M |
| 453 | MDXG | MiMedx Group, Inc. | 505.13M | -0.87% | 514,628 | 418.63M |
| 454 | UPB | Upstream Bio, Inc. | 505.02M | -0.22% | 161,963 | 2.85M |
| 455 | ESPR | Esperion Therapeutics, Inc. | 504.51M | 2.62% | 3,808,779 | 403.14M |
| 456 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 457 | ENGN | enGene Therapeutics Inc. | 500.41M | -6.51% | 638,316 | - |
| 458 | AQST | Aquestive Therapeutics, Inc. | 500.38M | 0.49% | 422,234 | 44.55M |
| 459 | VSTM | Verastem, Inc. | 497.19M | -4.23% | 570,519 | 30.91M |
| 460 | OFIX | Orthofix Medical Inc. | 496.59M | 0.16% | 74,087 | 822.31M |
| 461 | XOMA | XOMA Royalty Corporation | 493.07M | 9.18% | 2,298,076 | 52.15M |
| 462 | EIKN | Eikon Therapeutics, Inc. | 487.25M | -6.78% | 187,958 | - |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 486.01M | 1.28% | 249,740 | 85.21M |
| 464 | CATX | Perspective Therapeutics, Inc. | 485.15M | -5.65% | 850,324 | 884.00K |
| 465 | ADCT | ADC Therapeutics SA | 484.59M | -3.30% | 349,743 | 81.36M |
| 466 | BBNX | Beta Bionics, Inc. | 479.48M | -3.67% | 203,722 | 110.24M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 476.41M | 2.82% | 40,326 | - |
| 468 | KMDA | Kamada Ltd. | 471.87M | -0.72% | 29,900 | 180.46M |
| 469 | VALN | Valneva SE | 470.89M | 0.18% | 10,269 | 205.07M |
| 470 | PACB | Pacific Biosciences of California, Inc. | 469.61M | -0.32% | 4,753,031 | 160.01M |
| 471 | TRDA | Entrada Therapeutics, Inc. | 464.22M | 2.10% | 64,493 | 25.42M |
| 472 | CADL | Candel Therapeutics, Inc. | 463.65M | -2.62% | 812,052 | - |
| 473 | FLGT | Fulgent Genetics, Inc. | 461.51M | -1.90% | 184,052 | 322.67M |
| 474 | OVID | Ovid Therapeutics Inc. | 460.28M | 2.31% | 581,812 | 7.25M |
| 475 | ANGO | AngioDynamics, Inc. | 459.75M | -0.63% | 67,355 | 313.73M |
| 476 | PRLD | Prelude Therapeutics Incorporated | 458.52M | -2.98% | 381,570 | 12.14M |
| 477 | LRMR | Larimar Therapeutics, Inc. | 458.12M | -2.86% | 838,553 | - |
| 478 | DNA | Ginkgo Bioworks Holdings, Inc. | 455.18M | -0.64% | 379,500 | 170.16M |
| 479 | CLYM | Climb Bio, Inc. | 454.28M | 4.05% | 211,599 | - |
| 480 | MYGN | Myriad Genetics, Inc. | 450.49M | -0.21% | 366,255 | 824.50M |
| 481 | AURA | Aura Biosciences, Inc. | 449.40M | -3.71% | 72,260 | - |
| 482 | RGNX | REGENXBIO Inc. | 448.97M | -0.71% | 216,303 | 170.44M |
| 483 | CGC | Canopy Growth Corporation | 448.11M | - | 9,463,463 | 203.04M |
| 484 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.11M | - | 155,730 | - |
| 485 | ASMB | Assembly Biosciences, Inc. | 441.78M | -0.07% | 23,581 | 72.30M |
| 486 | AVIR | Atea Pharmaceuticals, Inc. | 433.02M | -0.64% | 74,193 | - |
| 487 | SRTA | Strata Critical Medical, Inc. | 429.64M | 1.02% | 255,168 | 197.14M |
| 488 | BNTC | Benitec Biopharma Inc. | 426.47M | 0.65% | 102,070 | - |
| 489 | NGNE | Neurogene Inc. | 425.92M | 0.91% | 55,968 | 925.00K |
| 490 | LXEO | Lexeo Therapeutics, Inc. | 422.67M | -2.48% | 428,693 | - |
| 491 | IVVD | Invivyd, Inc. | 418.55M | 1.37% | 648,730 | 53.43M |
| 492 | EBS | Emergent BioSolutions Inc. | 416.25M | 0.37% | 220,200 | 742.90M |
| 493 | AGL | agilon health, inc. | 412.71M | -5.11% | 182,029 | 5.93B |
| 494 | NMRA | Neumora Therapeutics, Inc. | 408.31M | -0.67% | 366,751 | - |
| 495 | KIDS | OrthoPediatrics Corp. | 406.61M | -2.22% | 41,500 | 236.35M |
| 496 | VNDA | Vanda Pharmaceuticals Inc. | 404.89M | -0.58% | 921,051 | 216.11M |
| 497 | IPSC | Century Therapeutics, Inc. | 403.33M | 0.90% | 259,005 | 109.16M |
| 498 | ARMP | Armata Pharmaceuticals, Inc. | 402.96M | -14.86% | 162,951 | 4.90M |
| 499 | PRTC | PureTech Health plc | 402.93M | 4.28% | 2,904 | 6.39M |
| 500 | NAGE | Niagen Bioscience, Inc. | 398.03M | 0.61% | 385,695 | 129.42M |